ClinicalTrials.Veeva

Menu

L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols

T

Tel Aviv Sourasky Medical Center

Status

Completed

Conditions

Asymmetric Dimethylarginine
Arginine
Obesity
Diabetes Mellitus, Type 2

Treatments

Behavioral: Acute dietary protocols and lifestyle modification

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Low serum L-arginine (Arg) and high asymmetric dimethylarginine (ADMA) can predict microvascular complications in type 2 diabetes (T2DM). The investigators examined whether or not Arg and ADMA are affected by dietary factors or lifestyle modification in overweight/ obese and T2DM subjects.

Full description

The investigators tested the effects on serum Arg and ADMA of a) a single load of ingested dextrose, protein, fat or alcohol, each consumed within 10 minutes; b) a single episode of physical exercise; c) a 12 weeks lifestyle modification program comprised of a standard dietary and physical activity counseling in obese or T2DM subjects on circulating Arg and ADMA (n=43)

Enrollment

243 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • obese and/ or T2DM subjects

Exclusion criteria

  • type 1 diabetes
  • insulin-treated T2DM
  • active coronary disease (recent [≤ 6months] myocardial infarction, unstable angina, recent coronary catheterization, or coronary bypass grafting
  • individuals with significant impairment in liver enzymes (≥ 2.5 the upper limit of the normal range)
  • serum creatinine higher than 1.5mg%
  • known malabsorption, alcoholism or illicit use of drugs
  • abnormal thyroid function tests
  • concomitant or recent use of glucocorticoids
  • uncertain mental state (to avoid invalid informed consent or lack of compliance).

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

243 participants in 6 patient groups

Acute glucose tolerance test
Experimental group
Description:
A standard oral glucose tolerance test (75 grams of dextrose in 180 cc of water)
Treatment:
Behavioral: Acute dietary protocols and lifestyle modification
Acute protein load test
Experimental group
Description:
A protein-rich, vanilla-flavored powder (Pro-gym, Telpharma, Is
Treatment:
Behavioral: Acute dietary protocols and lifestyle modification
Acute fat load test
Experimental group
Description:
a 100-gram portion of sweet cream containing 300 Kacls, of which 94% of the ingested calories were fat
Treatment:
Behavioral: Acute dietary protocols and lifestyle modification
Acute alcohol load test
Experimental group
Description:
Vodka (100 cc, 40% alcohol)
Treatment:
Behavioral: Acute dietary protocols and lifestyle modification
Acute exercise
Experimental group
Description:
30 minutes of supervised graded walking on a treadmill according to each subject's individual ability. A goal heart rate was calculated as 70% of the age-adjusted maximal allowable heart rate.
Treatment:
Behavioral: Acute dietary protocols and lifestyle modification
Lifestyle modification program - 12 weeks
Experimental group
Description:
12 weeks of weight-loss dietary program constructed according to the guidelines of the American Diabetes Association. Based on weight, gender, and age, daily dietary allowance varied at 1200-1800 Kcal, 50% carbohydrates, 20% protein, and 30% fat. Participants were also asked to engage in moderate physical activity comprised of a 40-minute walk three times a week. A weekly clinic visit alternating with a weekly telephone contact was also required.
Treatment:
Behavioral: Acute dietary protocols and lifestyle modification

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems